Elevance Health CFO has 4,161 shares withheld for taxes

The reported entries include a lapse of restrictions on performance-based units and tax withholding tied to previously granted restricted stock.

Filing Impact

(Very High)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Elevance Health, Inc. (ELV) EVP & CFO Mark Kaye reported 4,161 shares withheld to pay tax liability in connection with vesting of previously granted restricted stock on October 2, 2026; the reported price was $386.43 per share. He also acquired 2,627 shares represented by performance-based restricted share units whose restrictions lapsed that day. No Rule 10b5-1 plan is reported.

Insights

Analyzing...

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Kaye Mark

Role EVP & CFO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock ^F1	4,161	$386.43	$1.61M
Grant/Award	Common Stock ^F2	2,627	$0.00	$0.00

Holdings After Transaction: Common Stock — 30,503 shares (Direct)

Footnotes (2)

F1. PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2. Represents performance based restricted share units. Restrictions lapsed on 10/2/2026.

Key Figures

Shares withheld for tax liability: 4,161 shares Shares acquired: 2,627 shares Reported price per share: $386.43 per share

3 metrics

Shares withheld for tax liability 4,161 shares On October 2, 2026, in connection with vesting of previously granted restricted stock

Shares acquired 2,627 shares Performance-based restricted share units whose restrictions lapsed on October 2, 2026

Reported price per share $386.43 per share Shares withheld for tax liability

Key Terms

performance based restricted share units, tax liability, restrictions lapsed

3 terms

tax liability financial

"PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK"

restrictions lapsed financial

"Restrictions lapsed"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did ELV EVP & CFO Mark Kaye acquire and have withheld?

Mark Kaye acquired 2,627 shares represented by performance-based restricted share units whose restrictions lapsed on October 2, 2026, and 4,161 shares were withheld to pay tax liability on vesting of previously granted restricted stock. No Rule 10b5-1 plan is reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/06/2026 - 04:03 PM Accepted by SEC EDGAR 10/06/2026 - 04:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kaye Mark

(Last)

(First)

(Middle)

220 VIRGINIA AVENUE

(Street)

INDIANAPOLIS

INDIANA

46204

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP & CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/02/2026		F		4,161⁽¹⁾	D	$386.43	27,876	D
Common Stock	10/02/2026		A		2,627⁽²⁾	A	$0	30,503	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

2. Represents performance based restricted share units. Restrictions lapsed on 10/2/2026.

Remarks:

	/s/ Kathleen S. Kiefer, Attorney in fact	10/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR